
Congress trades
Encompass Health Corporation (EHC)
NYSE · Healthcare · 14 congress trades · last filed 11 months ago
About Encompass Health Corporation
from the company's filings and listing, as of Oct 25, 2026- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Chief executive
- Mark J. Tarr
- Employees
- 29,699
- Listed since
- Sep 24, 1986
- Market value
- $12.2B
- Price to earnings (12 mo)
- 20.0
- Net income per share, as reported (12 mo)
- $6.29
- Dividend yield
- 0.63%
Earnings
6 reported quarters · next on Oct 28, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Aug 5, 2026 | $1.55 | $1.48 | $1.6B | $1.6B | EPS beat, GAAPRevenue beat |
| Q1 FY2026reported Apr 30, 2026 | $1.60 | $1.51 | $1.6B | $1.6B | EPS beatRevenue in line |
| Q4 FY2025reported Feb 5, 2026 | $1.46 | $1.29 | $1.5B | $1.5B | EPS beatRevenue in line |
| Q3 FY2025reported Oct 29, 2025 | $1.23 | $1.19 | $1.5B | $1.5B | EPS beat, GAAPRevenue in line |
| Q2 FY2025reported Aug 5, 2025 | $1.40 | $1.23 | $1.5B | $1.4B | EPS beat, GAAPRevenue beat |
| Q1 FY2025reported Apr 24, 2025 | $1.37 | $1.19 | $1.5B | $1.4B | EPS beatRevenue beat |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for fiscal 2025 · proxy filed Apr 7, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Mark J. TarrPresident and Chief Executive Officer | $1.1M | $5.3M | $3.9M | $10.3M |
| Douglas E. ColtharpExecutive Vice President and Chief Financial Officer | $750K | $2.0M | $1.8M | $4.5M |
| Patrick W. TuerExecutive Vice President and Chief Operating Officer | $550K | $1.4M | $868K | $2.8M |
| Patrick DarbyExecutive Vice President, General Counsel and Secretary | $625K | $964K | $1.1M | $2.7M |
| Elissa J. CharbonneauChief Medical Officer | $435K | $518K | $491K | $1.4M |
The summary compensation table from the proxy statement for fiscal 2025, with titles as filed then. Executives who have since left are not shown. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Shares vs prior qtr | % of shares out |
|---|---|---|---|---|
| BlackRock, Inc. | $1.1B | 10,484,385 | -2.6% | 10.61% |
| T. Rowe Price Associates, Inc. | $511.0M | 5,055,801 | +9.9% | 5.12% |
| Vanguard Portfolio Management LLC | $497.8M | 4,924,664 | -0.7% | 4.98% |
| Vanguard Capital Management LLC | $452.4M | 4,475,896 | +0.2% | 4.53% |
| Wellington Management Group LLP | $331.4M | 3,278,739 | -14.8% | 3.32% |
| State Street Corp | $322.0M | 3,185,798 | +1.3% | 3.21% |
| Citadel Advisors LLCKen Griffin | $259.1M | 2,563,104 | +400.7% | 2.59% |
| Fuller & Thaler Asset Management, Inc. | $248.7M | 2,460,657 | +10.3% | 2.49% |
| AllianceBernstein L.P. | $239.1M | 2,471,751 | -5.7% | 2.50% |
| Two Sigma Investments, LP | $229.2M | 2,267,668 | +2.1% | 2.30% |
| Geode Capital Management, LLC | $191.2M | 1,890,743 | -0.4% | 1.91% |
| Dimensional Fund Advisors LP | $176.2M | 1,743,028 | +4.1% | 1.76% |
A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.
Congress trades in EHC
14 disclosures of 14 on record · median 23d of the 45 allowedSince the trade: the stock's move from the trade date to the latest close we hold (figures as of Oct 24, 2026), not the member's result. Not investment advice.
| Member | Type | Action | Amount disclosed | Stock since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Lisa C. McClainSpouse | Stock | Sale | $1,001 - $15,000 | +6.2%After the saleS&P 500 +11.7% · -5.5 pts vs S&P 500 | Oct 30, 2025 | Nov 21, 2025 | 22d |
| Lisa C. McClainSpouse | Stock | Purchase | $1,001 - $15,000 | +6.2%S&P 500 +11.7% · -5.5 pts vs S&P 500 | Oct 30, 2025 | Nov 21, 2025 | 22d |
| Lisa C. McClainSpouse | Stock | Sale | $1,001 - $15,000 | +9.0%After the saleS&P 500 +11.4% · -2.4 pts vs S&P 500 | Oct 31, 2025 | Nov 21, 2025 | 21d |
| Lisa C. McClainSpouse | Stock | Purchase | $1,001 - $15,000 | +14.5%S&P 500 +20.9% · -6.4 pts vs S&P 500 | Jul 22, 2025 | Aug 13, 2025 | 22d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +134.0%After the saleS&P 500 +94.1% · +39.9 pts vs S&P 500 | Mar 14, 2023 | Apr 7, 2023 | 24d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +102.3%S&P 500 +134.7% · -32.4 pts vs S&P 500 | Sep 23, 2020 | Oct 21, 2020 | 28d |
| Susie LeeJoint | Stock | Sale | $1,001 - $15,000 | +90.5%After the saleS&P 500 +118.3% · -27.8 pts vs S&P 500 | Aug 27, 2020 | Oct 7, 2020 | 41d |
| Susie LeeJoint | Stock | Purchase | $1,001 - $15,000 | +72.0%S&P 500 +160.2% · -88.1 pts vs S&P 500 | May 19, 2020 | Jun 15, 2020 | 27d |
| Susie LeeJoint | Stock | Sale | $1,001 - $15,000 | +94.4%After the saleS&P 500 +155.8% · -61.4 pts vs S&P 500 | Jul 31, 2019 | Aug 29, 2019 | 29d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +108.2%After the saleS&P 500 +177.1% · -68.9 pts vs S&P 500 | Jun 3, 2019 | Jul 11, 2019 | 38d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +109.8%After the saleS&P 500 +171.4% · -61.6 pts vs S&P 500 | May 28, 2019 | Jun 11, 2019 | 14d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +100.2%S&P 500 +159.8% · -59.5 pts vs S&P 500 | Apr 23, 2019 | May 10, 2019 | 17d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +109.3%S&P 500 +170.7% · -61.4 pts vs S&P 500 | Mar 26, 2019 | Apr 11, 2019 | 16d |
| Susie LeeJoint | Stock | Purchase | $1,001 - $15,000 | +107.8%S&P 500 +168.8% · -61.1 pts vs S&P 500 | Mar 15, 2019 | Apr 8, 2019 | 24d |
Since the trade is an estimate, set beside the S&P 500 over the same window, with the gap between the two in percentage points. The filing carries a band, not a fill, and a sale keeps the stock's sign, so a positive figure after a sale means the stock kept rising after it. An option row carries the underlying stock's move. A row marked n/a is one we hold no figure for.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no since-the-trade figure is computed from them.
Every Congress trade in EHC, filterable by party, chamber, type and account.
Questions
Which members of Congress have traded EHC?
Lisa C. McClain, Ro Khanna and Susie Lee disclosed EHC transactions in the filings shown here.
How quickly are EHC trades disclosed?
Congressional disclosures took a median of 23 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Oct 26, 2026.
